Early manifestations and differential gene expression associated with photoreceptor degeneration in Prom1-deficient retina.
Yuka KobayashiShizuka WatanabeAgnes Lee Chen OngManabu ShiraiChiemi YamashiroTadahiko OgataFumiaki HigashijimaTakuya YoshimotoTakahide HayanoYoshiyuki AsaiNoriaki SasaiKazuhiro KimuraPublished in: Disease models & mechanisms (2021)
Retinitis pigmentosa (RP) and macular dystrophy (MD) are characterized by gradual photoreceptor death in the retina and are often associated with genetic mutations, including those in the prominin-1 (Prom1) gene. Prom1-knockout (KO) mice recapitulate key features of these diseases including light-dependent retinal degeneration and constriction of retinal blood vessels. The mechanisms underlying such degeneration have remained unclear, however. We here analysed early events associated with retinal degeneration in Prom1-KO mice. We found that photoreceptor cell death and glial cell activation occur between 2 and 3 weeks after birth. Whereas gene expression was not affected at 2 weeks, the expression of several genes was altered at 3 weeks in the Prom1-KO retina, with the expression of that for endothelin-2 (Edn2) being markedly upregulated. Expression of Edn2 was also induced by light stimulation in Prom1-KO mice reared in the dark. Treatment with endothelin receptor antagonists attenuated photoreceptor cell death, gliosis and retinal vessel stenosis in Prom1-KO mice. Our findings thus reveal early manifestations of retinal degeneration in a model of RP/MD and suggest potential therapeutic agents for these diseases. This article has an associated First Person interview with the first author of the paper.
Keyphrases
- diabetic retinopathy
- optical coherence tomography
- optic nerve
- gene expression
- cell death
- poor prognosis
- high fat diet induced
- genome wide
- dna methylation
- wild type
- gestational age
- molecular dynamics
- binding protein
- type diabetes
- neuropathic pain
- adipose tissue
- stem cells
- cell cycle arrest
- cell therapy
- spinal cord
- metabolic syndrome
- early onset
- bone marrow
- pi k akt